SCIESCOPUSQ2
Clinical Genitourinary Cancer
CIG MEDIA GROUP, LP, United States
Clinical Genitourinary Cancer is an academic journal published by CIG MEDIA GROUP, LP (United States). Identifiers: ISSN 1558-7673, eISSN 1938-0682. Indexed in SCIE, SCOPUS. Metrics: JIF 2.7, CiteScore 3.9, SJR 1.130, SNIP 0.85. Subject areas: ONCOLOGY, UROLOGY & NEPHROLOGY. tlooto lists 3,015 papers from this journal.
CiteScore
3.90
Scopus citation metric
SJR
1.130
SCImago rank
SNIP
0.85
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1558-7673
- eISSN
- 1938-0682
- Abbreviation
- CLIN GENITOURIN CANC
- Publisher
- CIG MEDIA GROUP, LP
- Country
- United States
Web of Science categories
SCIEONCOLOGY, UROLOGY & NEPHROLOGY
Scopus ASJC categories
2730 Oncology2748 Urology
Keywords
Oncology | Urology & Nephrology
Papers in this journal
Recent papers
- Comprehensive Analysis of Tumor Mutational Burden in Prostate Cancer: Multipublic Dataset Analysis.
2026
- De-escalation of Treatment in Metastatic Renal Cell Carcinoma: Why? How? Who? When?
2026
- Retraction notice to " Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma"[Clinical Genitourinary Cancer 23/6 (2025) 102422].
2026
- Interpretation of Comparative Outcomes in Bone-Metastatic Clear Cell Renal Cell Carcinoma.
2026
- Quantitative Assessment of Seminoma in the Testicle Among Nonseminomatous Germ Cell Tumor Patients on Operative Difficulty, Morbidity and Pathological Outcomes at Postchemotherapy RPLND.
2026
Most cited papers
- Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy.
2013 · 192 citations
- Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma.
2007 · 187 citations
- Trends in renal cell carcinoma incidence and mortality in the US in the last two decades; SEER-based study
2018 · 183 citations
- Phase I Study Combining Treatment with Temsirolimus and Sunitinib Malate in Patients with Advanced Renal Cell Carcinoma
2009 · 182 citations
- Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States.
2020 · 168 citations